Johnson & Johnson Services, Inc.
Industry / private company
Location:
New Brunswick (NJ),
United States (USA) (US)
ISNI: -
ROR: https://ror.org/03qd7mz70
GUSELKUMAB IMPROVES DACTYLITIS IN PSA PATIENTS WITH INADEQUATE RESPONSE TO TNFI: DATA FROM THE PHASE 3B COSMOS TRIAL (2022)
Marzo-Ortega H, Theander E, Neuhold M, Bergmans P, Shawi M, Perate M, Contre C, et al.
Conference contribution
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic (2017)
O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, et al.
Journal article
Potentiation of evoked calcitonin gene-related peptide release from oral mucosa: a potential basis for the pro-inflammatory effects of nicotine (2003)
Dussor GO, Leong AS, Gracia NB, Kilo S, Price TJ, Hargreaves KM, Flores CM
Journal article
Capsaicin-evoked CGRP release from rat buccal mucosa: development of a model system for studying trigeminal mechanisms of neurogenic inflammation (2001)
Flores CM, Leong AS, Dussor GO, Harding-Rose C, Hargreaves KM, Kilo S
Journal article
Peripheral CGRP release as a marker for neurogenic inflammation: a model system for the study of neuropeptide secretion in rat paw skin (1997)
Kilo S, Harding-Rose C, Hargreaves KM, Flores CM
Journal article
Attenuation of peripheral inflammation by nicotine: Comparison of neuropeptide secretion and behavioral responses in the rat. (1997)
Kilo S, Hargreaves KM, Flores CM
Other publication type
Neuronal nicotinic receptor expression in sensory neurons of the rat trigeminal ganglion: Demonstration of alpha 3 beta 4, a novel subtype in the mammalian nervous system (1996)
Flores CM, DeCamp RM, Kilo S, Rogers SW, Hargreaves KM
Journal article, Original article